BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma
{{output}}
Background: In patients with stage III melanoma, the use of adjuvant radiation therapy (RT) after lymph node dissection (LND) may be currently considered in selected high-risk patients to improve tumor control. Melanomas harbor B... ...
